Literature DB >> 2838552

A chronic inflammatory response. Its role in supporting the development of c-myb and c-myc related promonocytic and monocytic tumors in BALB/c mice.

L Wolff1, J F Mushinski, G L Shen-Ong, H C Morse.   

Abstract

This study demonstrates that an inflammatory response caused by the injection of pristane into the peritoneal cavity of mice provides a useful system for rapid induction of myeloid tumors by retroviruses. Two such tumors, which developed in the peritoneal cavity with average latencies of 68 to 71 d and incidences of greater than 50%, are 1) the McML, mature monocyte-macrophage tumors induced by retroviral constructs containing exons 2 and 3 of c-myc cDNA, and 2) the MML, promonocytic tumors induced by Moloney murine leukemia virus infection and its integration into the c-myb locus. Development of both neoplasms is clearly dependent on the intense i.p. inflammatory response, inasmuch as mice given the viruses and not pristane fail to develop these tumors. Although both types of tumors appear in the peritoneal cavity, the MML tumors that arise by i.v. injection of Moloney murine leukemia virus may actually originate via infection, and perhaps transformation, of precursor hemopoietic cells outside the peritoneal cavity, followed by migration of the cells to the peritoneal cavity. This is suggested by the fact that i.v.v but not i.p. injection of virus is an efficient method of producing these particular myeloid tumors. Although both McML and MML tumors require the inflammatory environment for their development, treatment of mice with a nonsteroid anti-inflammatory drug, indomethacin, has no effect on McML monocyte/macrophage tumors but completely prevents the development of the MML promonocyte tumors.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2838552

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  14 in total

1.  Acute myeloid leukemia induction by amphotropic murine retrovirus (4070A): clonal integrations involve c-myb in some but not all leukemias.

Authors:  L Wolff; R Koller; W Davidson
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

2.  Gene Transfer to HSCs: Finding the Leukemia in Murine Leukemia Viruses.

Authors:  Kenneth Cornetta
Journal:  Mol Ther       Date:  2019-05-17       Impact factor: 11.454

3.  Three murine leukemia virus integration regions within 100 kilobases upstream of c-myb are proximal to the 5' regulatory region of the gene through DNA looping.

Authors:  Junfang Zhang; Jan Markus; Juraj Bies; Thomas Paul; Linda Wolff
Journal:  J Virol       Date:  2012-07-18       Impact factor: 5.103

4.  Regulation of the resident chromosomal copy of c-myc by c-Myb is involved in myeloid leukemogenesis.

Authors:  M Schmidt; V Nazarov; L Stevens; R Watson; L Wolff
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

5.  Regions of the Moloney murine leukemia virus genome specifically related to induction of promonocytic tumors.

Authors:  L Wolff; R Koller
Journal:  J Virol       Date:  1990-01       Impact factor: 5.103

6.  Proviral activation of the c-myb proto-oncogene is detectable in preleukemic mice infected neonatally with Moloney murine leukemia virus but not in resulting end stage T lymphomas.

Authors:  B Belli; L Wolff; V Nazarov; H Fan
Journal:  J Virol       Date:  1995-08       Impact factor: 5.103

7.  A Moloney murine leukemia virus-based retrovirus with 4070A long terminal repeat sequences induces a high incidence of myeloid as well as lymphoid neoplasms.

Authors:  Linda Wolff; Richard Koller; Xinrong Hu; Miriam R Anver
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

8.  Characterization of human larynx carcinoma cell lines HLaC'79 and HLaC'82: a common origin but diverged malignancies.

Authors:  A M Tomson; J Scholma; T Dijkhuizen; A P Wijnakker; M van der Werf; K M de Jong; M B van Leeuwen; J G Koning
Journal:  Clin Exp Metastasis       Date:  1995-09       Impact factor: 5.150

9.  Moloney murine leukemia virus activates NF-kappa B.

Authors:  J Pak; D V Faller
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

10.  New sites of proviral integration associated with murine promonocytic leukemias and evidence for alternate modes of c-myb activation.

Authors:  R Mukhopadhyaya; L Wolff
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.